Further, administration of SPHK1 inhibitor, SKI-II to mice attenuated bleomycin-induced lung inflammation and collagen deposition in lungs confirming a role for SPHK1-mediated S1P in the development of PF [126]. The gene discussed is SPHK1; the disease is inflammation.